Skip to main content

Table 4 Comparison of IgG4-related thyroiditis in this study with Non-IgG4 related thyroiditis of HT in previous study

From: Clinical features and treatment efficacy for IgG4-related thyroiditis

Demographic features Our study
IgG4-related thyroiditis
Li’s study [16]
Non-IgG4
thyroiditis in HT
Li’s study [9]
Non-IgG4
thyroiditis in HT
P value
Sample size 14 51 93 NA
Age (years) 42.8 ± 14.9 57.7 ± 8.6 58.12 ± 10.05 NA
Disease duration(yr) 4.1 ± 4.0 17.11 ± 10.34 14.88 ± 10.13 NA
Male/Female ratio 1:1 1:16 5:88 0.036*
Tg-Ab (Normal upper limit multiple) 27.58 ± 13.18 3.53 ± 6.79 1.73 (0.92–3.24) NA
TPO-Ab (Normal upper limit multiple) 13.97 ± 4.78 2.55 ± 7.42 0.94 (0.60–1. 46) NA
Thyroid functional status (subclinical hypo-/eu-/subclinical hyper-) 13/1/0 5/36/8 10/61/12  < 0.001*
  1. HT: Hashimoto’s thyroiditis; Tg-Ab: serum thyroglobulin autoantibodies, TPO-Ab: thyroid peroxidase antibodies; subclinical hypo: subclinical hypothyroidism; eu: euthyroid; subclinical hyper: subclinical hyperthyroidism
  2. *Represented statistical significance